Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium Infusion for Conversion of Atrial Fibrillation/Flutter
NCT01818583Phase 4Completed
- Sponsor
- Diakonhjemmet Sykehus
- Start
- Mar 2013
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of potassium chloride in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Diakonhjemmet Sykehus. Started Mar 2013; status: completed.
02
Drugs
potassium chloride
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT01818583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818583.